Founders Capital Management, LLC Bristol Myers Squibb CO Transaction History

Founders Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	BUY	$61.48 - $73.72 $186,899 - $224,108	3,040 New	3,040 $222,000
Q3 2021 Oct 21, 2021	SELL	$59.17 - $69.31 $208,574 - $244,317	-3,525 Closed	0 $0
Q2 2021 Jul 15, 2021	SELL	$61.91 - $67.42 $56,647 - $61,689	-915 Reduced 20.61%	3,525 $236,000
Q1 2021 Apr 12, 2021	BUY	$59.34 - $66.74 $59,340 - $66,740	1,000 Added 29.07%	4,440 $280,000
Q4 2020 Jan 15, 2021	BUY	$57.74 - $65.43 $198,625 - $225,079	3,440 New	3,440 $213,000
Q4 2018 Jan 15, 2019	SELL	$48.76 - $63.23 $263,255 - $341,378	-5,399 Closed	0 $0
Q3 2018 Oct 11, 2018	SELL	$55.19 - $62.25 $220 - $249	-4 Reduced 0.07%	5,399 $341,000
Q1 2018 Apr 04, 2018	BUY	$59.92 - $68.98 $76,697 - $88,294	1,280 Added 31.05%	5,403 $335,000
Q3 2017 Oct 16, 2017	BUY	$55.23 - $63.74 $227,713 - $262,800	4,123	4,123 $263,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Founders Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Founders Capital Management, LLC with notifications on news.